chevron_leftBack
As of 24 April 2025, Caplin Point Laboratories Ltd. has a market cap of $1.68B USD, ranking #5982 globally and #413 in India. It ranks #558 in the Healthcare sector, and #119 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$1.68BUSD
143.67B INR
Enterprise Value
$1.6BUSD
136.5B INR
Revenue (TTM)
$221.28MUSD
18.9B INR
EBITDA (TTM)
$72.23MUSD
6.18B INR
Net Income (TTM)
$60.33MUSD
5.15B INR
EBITDA Margin
33%
Profit Margin
27%
PE Ratio
27.9
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Sridhar Ganesan
open_in_new
Employees
3,406
Founded
1990
Website
caplinpoint.net
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.1% | 1% | -5.5% | -14% | -0.5% | 44% |
Upcoming Earnings
Earnings Date
Wed, May 14
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CAPLIPOINT
Caplin Point Laboratories Ltd
ISIN: INE475E01026
Shares Out.:
Shares Outstanding:
76.012M1
Shares Float:
20.319M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.89K INR | |
|
524742
(CAPLIPOINT)
Caplin Point Laboratories Ltd
ISIN: INE475E01026
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.96K INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Caplin Point Laboratories Ltd.
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
